advertisement
Kojima S 82
Showing records 1 to 25 | Display only abstracts from Kojima S in IGR 23-3117152 Long-term intraocular pressure-lowering efficacy and safety of ripasudil-brimonidine fixed-dose combination for glaucoma and ocular hypertension: a multicentre, open-label, phase 3 study
Tanihara H
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 2579-2591 (IGR: 24-4)
118231 Trabeculotomy Using the Kahook Dual Blade for Exfoliation Glaucoma and Primary Open Angle Glaucoma: Comparison of Outcomes According to Incision Range
Irie A; Nakashima KI
Journal of Glaucoma 2024; 33: 270-276 (IGR: 24-4)
117152 Long-term intraocular pressure-lowering efficacy and safety of ripasudil-brimonidine fixed-dose combination for glaucoma and ocular hypertension: a multicentre, open-label, phase 3 study
Yamamoto T
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 2579-2591 (IGR: 24-4)
118231 Trabeculotomy Using the Kahook Dual Blade for Exfoliation Glaucoma and Primary Open Angle Glaucoma: Comparison of Outcomes According to Incision Range
Inoue T
Journal of Glaucoma 2024; 33: 270-276 (IGR: 24-4)
117152 Long-term intraocular pressure-lowering efficacy and safety of ripasudil-brimonidine fixed-dose combination for glaucoma and ocular hypertension: a multicentre, open-label, phase 3 study
Aihara M
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 2579-2591 (IGR: 24-4)
118231 Trabeculotomy Using the Kahook Dual Blade for Exfoliation Glaucoma and Primary Open Angle Glaucoma: Comparison of Outcomes According to Incision Range
Kojima S
Journal of Glaucoma 2024; 33: 270-276 (IGR: 24-4)
117152 Long-term intraocular pressure-lowering efficacy and safety of ripasudil-brimonidine fixed-dose combination for glaucoma and ocular hypertension: a multicentre, open-label, phase 3 study
Koizumi N
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 2579-2591 (IGR: 24-4)
118231 Trabeculotomy Using the Kahook Dual Blade for Exfoliation Glaucoma and Primary Open Angle Glaucoma: Comparison of Outcomes According to Incision Range
Takihara Y
Journal of Glaucoma 2024; 33: 270-276 (IGR: 24-4)
117152 Long-term intraocular pressure-lowering efficacy and safety of ripasudil-brimonidine fixed-dose combination for glaucoma and ocular hypertension: a multicentre, open-label, phase 3 study
Fukushima A; Kawakita K
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 2579-2591 (IGR: 24-4)
118231 Trabeculotomy Using the Kahook Dual Blade for Exfoliation Glaucoma and Primary Open Angle Glaucoma: Comparison of Outcomes According to Incision Range
Takahashi E
Journal of Glaucoma 2024; 33: 270-276 (IGR: 24-4)
117152 Long-term intraocular pressure-lowering efficacy and safety of ripasudil-brimonidine fixed-dose combination for glaucoma and ocular hypertension: a multicentre, open-label, phase 3 study
Kojima S; Nakamura T; Suganami H;
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 2579-2591 (IGR: 24-4)
109609 Crossover Randomized Study of Pharmacologic Effects of Ripasudil-Brimonidine Fixed-Dose Combination Versus Ripasudil or Brimonidine
Tanihara H; Yamamoto T; Aihara M; Koizumi N; Minami H; Kojima S; Isobe T; Kanazawa M; Suganami H;
Advances in Therapy 2023; 40: 3559-3573 (IGR: 24-1/2)
108135 Risk factors for Baerveldt glaucoma drainage implantation for uveitic glaucoma
Manako K; Takahashi E; Saruwatari J; Matsumura T; Kojima S; Inoue T
Scientific reports 2023; 13: 4473 (IGR: 23-4)
106411 Ripasudil-Brimonidine Fixed-Dose Combination vs Ripasudil or Brimonidine: Two Phase 3 Randomized Clinical Trials
Tanihara H; Yamamoto T; Aihara M; Kawakita K; Kojima S; Kanazawa M; Nojima T; Suganami H;
American Journal of Ophthalmology 2022; 248: 35-44 (IGR: 23-3)
104835 Elevated soluble vascular endothelial growth factor receptor levels in aqueous humor from patients with different types of glaucoma
Nakamura K
Experimental Eye Research 2022; 223: 109204 (IGR: 23-2)
104918 Outcomes and risk factors for ab interno trabeculotomy with a Kahook Dual Blade
Murata N; Takahashi E
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 503-511 (IGR: 23-2)
104835 Elevated soluble vascular endothelial growth factor receptor levels in aqueous humor from patients with different types of glaucoma
Kojima S
Experimental Eye Research 2022; 223: 109204 (IGR: 23-2)
104918 Outcomes and risk factors for ab interno trabeculotomy with a Kahook Dual Blade
Saruwatari J
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 503-511 (IGR: 23-2)
104835 Elevated soluble vascular endothelial growth factor receptor levels in aqueous humor from patients with different types of glaucoma
Inoue-Mochita M; Tanihara H
Experimental Eye Research 2022; 223: 109204 (IGR: 23-2)
104918 Outcomes and risk factors for ab interno trabeculotomy with a Kahook Dual Blade
Kojima S
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 503-511 (IGR: 23-2)
104835 Elevated soluble vascular endothelial growth factor receptor levels in aqueous humor from patients with different types of glaucoma
Inoue T
Experimental Eye Research 2022; 223: 109204 (IGR: 23-2)
104918 Outcomes and risk factors for ab interno trabeculotomy with a Kahook Dual Blade
Inoue T
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 503-511 (IGR: 23-2)
100657 Comparing Surgical Outcomes in Neovascular Glaucoma between Tube and Trabeculectomy: A Multicenter Study
Iwasaki K; Kojima S; Wajima R; Okazaki T; Yokoyama Y; Inoue T; Higashide T; Miki A; Nakazawa T; Inatani M
Ophthalmology. Glaucoma 2022; 5: 672-680 (IGR: 23-1)
98631 Factors associated with the surgical outcomes of Baerveldt glaucoma implant for open-angle glaucoma, an age-related eye disease
Iraha S; Takihara Y; Urahashi Y; Watanabe T; Nakamura K; Urahashi M; Watanabe-Kitamura F; Nakashima KI; Takahashi E; Kojima S; Tanihara H; Inoue T
Scientific reports 2022; 12: 1359 (IGR: 22-4)
95780 Three-year Outcomes of Pars Plana Ahmed and Baerveldt Glaucoma Implantations for Neovascular Glaucoma in Japanese Eyes
Maeda M; Ueki M; Sugiyama T; Kohmoto R; Nemoto E; Kojima S; Ikeda T
Journal of Glaucoma 2022; 31: 462-467 (IGR: 22-3)